ADAMTS13 and infection: Given the pivotal role of endothelial injury in ACLF pathogenesis, biomarkers such as vWF and ADAMTS13 may enhance risk stratification and enable earlier interventions, including infection prevention, trial enrollment, and timely liver transplant evaluation.